U.S., May 6 -- ClinicalTrials.gov registry received information related to the study (NCT07568275) titled 'Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance' on Feb. 19.
Brief Summary: A study to see whether a medication called Angiotensin II works better than the routinely used medication to raise blood pressure in people with liver disease who are experiencing a serious drop in blood pressure.
The investigators want to find out if Angiotensin II can help the heart and blood vessels work together more effectively than standard treatments.
Study Start Date: Nov. 15, 2024
Study Type: INTERVENTIONAL
Condition:
Septic Shock
Cirrhosis
Vasodilatory Shock
Acute Kidney Injury
Intervention:
DRUG: Gia...